Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation
Abstract: (−)‐Finerenone is a nonsteroidal mineralocorticoid receptor antagonist currently in phase III clinical trials for the treatment of chronic kidney disease in type 2 diabetes. It contains an unusual dihydronaphthyridine core. We report a 6‐step synthesis of (−)‐finerenone, which features an enantioselective partial transfer hydrogenation of a naphthyridine using a chiral phosphoric acid catalyst with a Hantzsch ester. The process is complicated by the fact that the naphthyridine exists as a mixture of two atropisomers that react at different rates and with different selectivities. The intrinsic kinetic resolution was converted into a kinetic dynamic resolution at elevated temperature, which enabled us to obtain (−)‐finerenone in both high yield and high enantioselectivity. DFT calculations have revealed the origin of selectivity.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Enantioselective Total Synthesis of (−)‐Finerenone Using Asymmetric Transfer Hydrogenation ; volume:59 ; number:51 ; year:2020 ; pages:23107-23111 ; extent:5
Angewandte Chemie / International edition. International edition ; 59, Heft 51 (2020), 23107-23111 (gesamt 5)
- Creator
-
Lerchen, Andreas
Gandhamsetty, Narasimhulu
Farrar, Elliot H. E.
Winter, Nils
Platzek, Johannes
Grayson, Matthew N.
Aggarwal, Varinder K.
- DOI
-
10.1002/anie.202011256
- URN
-
urn:nbn:de:101:1-2022061112313561079527
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lerchen, Andreas
- Gandhamsetty, Narasimhulu
- Farrar, Elliot H. E.
- Winter, Nils
- Platzek, Johannes
- Grayson, Matthew N.
- Aggarwal, Varinder K.